Jackson Wealth Management LLC Makes New $282,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Jackson Wealth Management LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 695 shares of the company’s stock, valued at approximately $282,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC purchased a new stake in HCA Healthcare in the second quarter valued at $28,000. Bangor Savings Bank lifted its position in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC lifted its position in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the second quarter valued at $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Morgan Stanley started coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Finally, Barclays boosted their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $367.15.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,345 shares of company stock valued at $5,747,945 over the last quarter. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock traded down $5.65 during trading hours on Thursday, hitting $404.38. The company’s stock had a trading volume of 594,599 shares, compared to its average volume of 1,134,552. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $105.91 billion, a price-to-earnings ratio of 20.44, a P/E/G ratio of 1.44 and a beta of 1.67. The business has a fifty day moving average of $394.72 and a 200-day moving average of $352.30. HCA Healthcare, Inc. has a twelve month low of $220.55 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.29 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.